Delivery Order SPE2DB20D9331-SPE2DB22FL0U8

Award Date 3/29/22
Potential Completion Date 4/19/22
Potential Value $86K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of 3,750 units of the drug Oncaspar (pegaspargase) in 5 mL vials. The contract, valued at $43,220.28, is a firm fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,765.70 contract covers the delivery of 3,750 units of the branded oncology medication Oncaspar (pegaspargase) in 5 mL vials. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $86,781.56 firm fixed-price contract is for the delivery of 3,750 units of the drug Oncaspar in 5 ML vials. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to...
This federal contract award, valued at $43,220.28, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,559,233,967 units of the oncology medication Oncaspar (pegaspargase) in 5 mL vials. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 delivery order is for 4,557 units of the oncology medication Oncaspar (Pegaspargase) 3,750 unit/5 mL vial. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA...
This is a delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $49,531.40 firm-fixed-price contract was issued by the Defense Logistics Agency (DLA) on March 19, 2024 and has an ultimate completion date of April 9, 2024. The award is for 4,564,042,836 units of the oncology drug ONCASPAR (pegaspargase) in 5 mL vials. There is no set-aside designation on this contract. DMS Pharmaceutical Group holds an indefinite delivery contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $86,440.56 contract is for the supply of 3,750 units of the oncology medication Oncaspar (Pegaspargase) in 5 ML vials. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to issue...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract award of $49,531.40 is for the delivery of 3,750 units of the oncology medication ONCASPAR 3,750 UNIT/5 ML VIAL 5ML. The contract is a firm fixed-price delivery order that does not have a set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order (SPE2DB22FPPM3) valued at $64,830.42 under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC). The order is for 3,750 units of the oncology medication Oncaspar (4558477509). DMS Pharmaceutical Group holds a $499,999,999 IDC with the DLA that enables the agency to issue delivery orders for a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $65,086.14 firm fixed-price delivery order covers the provision of 4,558,704,484 units of the injectable chemotherapy medication Oncaspar (pegaspargase) in 5 mL vials. The delivery order falls under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB22FL0U8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of Oncaspar (pegaspargase) 3,750 unit/5 mL vials. The order, valued at $86,440.56, is a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a broad range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This contract is part of DMS Pharmaceutical Group's broader role as a prime vendor for prescription drugs and pharmacy services to the Department of Defense, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 1/9/25, 9:14 AM